Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

PASW vs OPTO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PASW Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–1 Matrix Metrics)

PASW Overall Winner 6-Pillar Tally: PASW 5 – 0 OPTO (1 Tie) Matrix Metrics: PASW 7 – 1 OPTO

As of Nov 20, 2026, Ping An Biomedical Co., Ltd. (PASW) is the stronger overall head-to-head candidate over OPTO (OPTO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PASW carries a Unified Composite Score of 59.1/100 (HOLD) at $1.13 (N/M Forward P/E, -41.3% operating margin), whereas OPTO carries 47.3/100 (HOLD) at $12.11 (N/M Forward P/E, N/A operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PASW vs OPTO
PASW NASDAQ Head-to-Head Winner
Ping An Biomedical Co., Ltd. Ordinary Shares
Institutional Equity
$1.13
-10.32% 1D
Market Cap $3.6M
TTM Revenue $26M
Forward P/E N/M
Beta / 30D Vol -10.07β · 11691% Vol
Unified Composite Score
59.1 / 100 HOLD
Tech 60.0 Fund 47.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 41.8 · SMA20: $2.68 · SMA50: $1.24
OPTO US Equity
OPTO
Institutional Equity
$12.11
-12.53% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 3.64β · 108% Vol
Unified Composite Score
47.3 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A

6-Pillar Scorecard Institutional Category Breakdown (PASW 5 – 0 OPTO)

Columns: Metric · PASW · OPTO
1. Valuation Multiples PASW
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.1x N/M
2. Growth & Scale PASW
Revenue Growth (YoY) -47.4% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $26M N/A
Market Cap $3.6M N/A
3. Profitability & Quality PASW
Gross Margin 9.3% N/A
Operating Margin -41.3% N/A
Net Profit Margin -14.8% N/A
Return on Equity (ROE) -11.3% N/A
4. Balance Sheet & Cash Flow PASW
Cash Generation (TTM) -$11M EBITDA N/A
Cash Flow Margin -41.3% EBITDA Mgn N/A
Net Cash / Leverage $3.74 Book/Sh · -11.3% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat PASW
OpEx & R&D Intensity 50.6% of Rev ($13M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Textile Manufacturing Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PASW (7) vs OPTO (1)
Institutional Metric PASW OPTO Criterion Row Edge
Market Capitalization
Scale
$3.6M N/A Larger Scale PASW
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-47.4% N/A Higher Growth PASW
Operating Margin (TTM)
Profitability
-41.3% N/A Higher Margin PASW
Net Profit Margin
Profitability
-14.8% N/A Higher Margin PASW
Return on Equity (ROE)
Capital Efficiency
-11.3% N/A Higher ROE PASW
52-Week Range Position
Momentum
17% ($0–$6) 0% ($12–$26) Stronger Trend PASW
Beta / 30D Volatility
Risk Regime
-10.07β · 11691% Vol 3.64β · 108% Vol Lower Realized Risk OPTO
Unified Institutional Score
Composite Signal
59.1 / 100 (HOLD) 47.3 / 100 (HOLD) Higher Composite PASW
Trailing 12M Revenue (USD)
Operating Scale
$26M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
9.3% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$11M EBITDA ($3.74 Book/Sh · -11.3% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PASW +775.08 pp
PASW: +743.28% · OPTO: -31.8%
3M Horizon PASW +879.8 pp
PASW: +826.23% · OPTO: -53.57%
6M Horizon PASW +879.8 pp
PASW: +826.23% · OPTO: -53.57%
1Y Horizon PASW +879.8 pp
PASW: +826.23% · OPTO: -53.57%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PASW vs OPTO. Trailing 12-month operating profitability (PASW -41.3% vs OPTO N/A) and valuation multiples (PASW N/M vs OPTO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

PASW ADR TTM Benchmark FX-Normalized USD
TTM Revenue$26M
Gross Margin9.3%
Op. Margin-41.3%
ROE / Fwd P/E-11.3% · N/M
OPTO ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PASW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PASW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
OPTO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact OPTO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PASW Moat Profile Cyclical / Execution-Driven Positioning
Textile Manufacturing Operator
Competes within the Textile Manufacturing value chain with $3.6M market capitalization and -41.3% operating margin.
OpEx & R&D Reinvestment 50.6% of Rev ($13M)
90D Engineering Disclosures 0 Published
OPTO Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ PASW vs OPTO Key Questions & Quantitative Answers

As of Nov 20, 2026, Ping An Biomedical Co., Ltd. (PASW) is the stronger overall head-to-head candidate over OPTO (OPTO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PASW carries a Unified Composite Score of 59.1/100 (HOLD) at $1.13 (N/M Forward P/E, -41.3% operating margin), whereas OPTO carries 47.3/100 (HOLD) at $12.11 (N/M Forward P/E, N/A operating margin). Technically, PASW sits in a Neutral phase (RSI 41.8, UNCLASSIFIED options structure) and OPTO sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure).

PASW leads the Growth & Scale pillar: PASW posts -47.4% YoY revenue growth and +0.0% YoY earnings growth on $26M TTM revenue (9.3% gross margin, -41.3% operating margin), compared with OPTO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, PASW generates $26M in USD-normalized revenue versus N/A for OPTO. In operating R&D and SG&A reinvestment, PASW deploys 50.6% of Rev ($13M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for OPTO.

PASW screens cheaper on headline valuation multiples. PASW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-41.3% EBITDA margin), whereas OPTO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PASW (-11.3% ROE) versus OPTO (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, PASW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-10.07β · 11691% Vol realized risk). By comparison, OPTO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.64β · 108% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.